Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 260

1.

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.

Fousekis FS, Katsanos KH, Theopistos VI, Baltayiannis G, Kosmidou M, Glantzounis G, Christou L, Tsianos EV, Christodoulou DK.

BMC Gastroenterol. 2019 Apr 3;19(1):48. doi: 10.1186/s12876-019-0967-3.

2.

Presence of pseudopolyps in ulcerative colitis is associated with a higher risk for treatment escalation.

Politis DS, Papamichael K, Katsanos KH, Koulouridis I, Mavromati D, Tsianos EV, Christodoulou DK.

Ann Gastroenterol. 2019 Mar-Apr;32(2):168-173. doi: 10.20524/aog.2019.0357. Epub 2019 Jan 23. Review.

3.

Clinical Use of Patency Capsule: A Comprehensive Review of the Literature.

Mitselos IV, Katsanos K, Tsianos EV, Eliakim R, Christodoulou D.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2339-2347. doi: 10.1093/ibd/izy152. Review.

PMID:
29718225
4.

Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.

Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 7. Review.

5.

Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.

Mitselos IV, Katsanos KH, Tatsioni A, Skamnelos A, Eliakim R, Tsianos EV, Christodoulou DK.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):861-867. doi: 10.1097/MEG.0000000000001146.

PMID:
29697457
6.

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?

Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK.

World J Gastroenterol. 2017 Mar 7;23(9):1541-1551. doi: 10.3748/wjg.v23.i9.1541. Review.

7.

von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.

Kalambokis GN, Oikonomou A, Christou L, Kolaitis NI, Tsianos EV, Christodoulou D, Baltayiannis G.

J Hepatol. 2016 Nov;65(5):921-928. doi: 10.1016/j.jhep.2016.06.002. Epub 2016 Jun 11.

PMID:
27297911
8.

Irritable bowel syndrome might be associated with dry eye disease.

Asproudis I, Tsoumani AT, Katsanos KH, Katsanos AH, Theopistos V, Paschidis KA, Tsianos EV, Christodoulou D.

Ann Gastroenterol. 2016 Oct-Dec;29(4):487-491. Epub 2016 Jun 16.

9.

Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases.

Kyriakidi KS, Tsianos VE, Karvounis E, Christodoulou DK, Katsanos KH, Tsianos EV.

Ann Gastroenterol. 2016 Jul-Sep;29(3):258-67. doi: 10.20524/aog.2016.0028. Epub 2016 Mar 24. Review.

10.

The role of small bowel capsule endoscopy and ileocolonoscopy in patients with nonspecific but suggestive symptoms of Crohn's disease.

Mitselos IV, Christodoulou DK, Katsanos KH, Tatsioni A, Rapti A, Eliakim R, Tsianos EV.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):882-9. doi: 10.1097/MEG.0000000000000644.

PMID:
27183502
11.

European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.

Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV.

Eur J Gastroenterol Hepatol. 2016 Jul;28(7):802-6. doi: 10.1097/MEG.0000000000000609.

PMID:
26894634
12.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrance I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T.

J Crohns Colitis. 2016 Feb;10(2):149-58. doi: 10.1093/ecco-jcc/jjv219. Epub 2015 Nov 29. Erratum in: J Crohns Colitis. 2017 Dec 4;11(12):1509.

PMID:
26619893
13.

Familial inflammatory bowel diseases in Northwest Greece.

Katsanos KH, Giga A, Christodoulou DK, Tsianos EV; Northwest Greece IBD Study Group.

Ann Gastroenterol. 2015 Oct-Dec;28(4):507-9. No abstract available.

14.

CD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature.

Skamnelos A, Tatsioni A, Katsanos KH, Tsianos V, Christodoulou D, Tsianos EV.

Ann Gastroenterol. 2015 Jul-Sep;28(3):337-346. Review.

15.

Role of wireless capsule endoscopy in the follow-up of inflammatory bowel disease.

Mitselos IV, Christodoulou DK, Katsanos KH, Tsianos EV.

World J Gastrointest Endosc. 2015 Jun 10;7(6):643-51. doi: 10.4253/wjge.v7.i6.643. Review.

16.

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.

Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M, Vinding KK, Avnstrøm S, Olsen J, Nielsen KR, Katsanos KH, Tsianos EV, Lakatos L, Schwartz D, Odes S, D'Incà R, Beltrami M, Kiudelis G, Kupcinskap L, Jucov A, Turcan S, Barros LF, Magro F, Lazar D, Goldis A, de Castro L, Hernandez V, Niewiadomski O, Bell S, Langholz E, Munkholm P, Lakatos PL; EpiCom-group.

J Crohns Colitis. 2015 Sep;9(9):747-53. doi: 10.1093/ecco-jcc/jjv099. Epub 2015 Jun 7. Erratum in: J Crohns Colitis. 2015 Oct;9(10):939.

PMID:
26055976
17.

Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis.

Kalambokis GN, Oikonomou A, Baltayiannis G, Christou L, Kolaitis NI, Tsianos EV.

Hepatol Res. 2016 Mar;46(3):E36-44. doi: 10.1111/hepr.12520. Epub 2015 May 22.

PMID:
25847196
18.

Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.

Burisch J, Vardi H, Pedersen N, Brinar M, Cukovic-Cavka S, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, OʼMorain C, Schwartz D, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Pineda JR, Almer S, Halfvarson J, Tsai HH, Sebastian S, Friger M, Greenberg D, Lakatos PL, Langholz E, Odes S, Munkholm P; EpiCom Group.

Inflamm Bowel Dis. 2015 Jan;21(1):121-31. doi: 10.1097/MIB.0000000000000250.

PMID:
25437816
19.

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.

Heap GA, Weedon MN, Bewshea CM, Singh A, Chen M, Satchwell JB, Vivian JP, So K, Dubois PC, Andrews JM, Annese V, Bampton P, Barnardo M, Bell S, Cole A, Connor SJ, Creed T, Cummings FR, D'Amato M, Daneshmend TK, Fedorak RN, Florin TH, Gaya DR, Greig E, Halfvarson J, Hart A, Irving PM, Jones G, Karban A, Lawrance IC, Lee JC, Lees C, Lev-Tzion R, Lindsay JO, Mansfield J, Mawdsley J, Mazhar Z, Parkes M, Parnell K, Orchard TR, Radford-Smith G, Russell RK, Reffitt D, Satsangi J, Silverberg MS, Sturniolo GC, Tremelling M, Tsianos EV, van Heel DA, Walsh A, Watermeyer G, Weersma RK, Zeissig S, Rossjohn J, Holden AL; International Serious Adverse Events Consortium; IBD Pharmacogenetics Study Group, Ahmad T.

Nat Genet. 2014 Oct;46(10):1131-4. doi: 10.1038/ng.3093. Epub 2014 Sep 14.

20.

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.

Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M, Avnstrøm S, Vinding KK, Olsen J, Nielsen KR, Katsanos KH, Tsianos EV, Lakatos L, Schwartz D, Odes S, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Tighineanu O, Mihu I, Barros LF, Magro F, Lazar D, Goldis A, Fernandez A, Hernandez V, Niewiadomski O, Bell S, Langholz E, Munkholm P, Lakatos PL; EpiCom-group.

J Crohns Colitis. 2014 Nov;8(11):1506-15. doi: 10.1016/j.crohns.2014.06.004. Epub 2014 Jul 4.

PMID:
24998983

Supplemental Content

Loading ...
Support Center